Pathological response and tumor regression grading following neoadjuvant chemo-immunotherapy and chemotherapy in resectable non-small cell lung cancer.

Oncol Lett · 2026 · PMC13238962 · PMID 42256814

Europe PMC DOI

hedged sentences

0.0520

closest p · 1.0× alpha

0.0780

boldest claim

The sentences

borderline significantP=0.052so close (0.05 < p ≤ 0.1)

lymphocytic) was borderline significant (χ 2 =5.92; P=0.052; Table III ).

also in 11,409 other papers

approached significanceP=0.078so close (0.05 < p ≤ 0.1)

Statistical analysis showed that this difference approached significance (P=0.078; Table II ). pCR (stage ypT0N0) was observed in 37.5% (3/8) of patients in the CIT group and 13.6% (3/22) of those in the CT group.

also in 8,237 other papers

did not reach statistical significanceno p-value reported

22.7%), although these differences did not reach statistical significance. pCR occurred in 37.5% of patients treated with CIT and in 13.6% of patients treated with CT.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.